Sartorius Aktiengesellschaft (0NIQ.L)
EUR 192.8
(5.7%)
EUR 192.8
(5.7%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 9.75 Billion EUR | 39.45% |
| 2022 | 6.99 Billion EUR | 22.31% |
| 2021 | 5.71 Billion EUR | 26.78% |
| 2020 | 4.51 Billion EUR | 56.11% |
| 2019 | 2.88 Billion EUR | 13.58% |
| 2018 | 2.54 Billion EUR | 9.75% |
| 2017 | 2.31 Billion EUR | 31.2% |
| 2016 | 1.76 Billion EUR | 22.94% |
| 2015 | 1.43 Billion EUR | 12.9% |
| 2014 | 1.27 Billion EUR | 7.76% |
| 2013 | 1.18 Billion EUR | 10.31% |
| 2012 | 1.07 Billion EUR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 9.79 Billion EUR | -1.49% |
| 2024 Q2 | 9.94 Billion EUR | -6.45% |
| 2024 Q1 | 10.62 Billion EUR | 8.65% |
| 2023 Q4 | 9.78 Billion EUR | -1.8% |
| 2023 FY | 9.78 Billion EUR | 39.82% |
| 2023 Q1 | 6.96 Billion EUR | -0.44% |
| 2023 Q2 | 7.04 Billion EUR | 1.12% |
| 2023 Q3 | 9.96 Billion EUR | 41.43% |
| 2022 Q3 | 7.09 Billion EUR | 13.5% |
| 2022 Q1 | 5.93 Billion EUR | 3.69% |
| 2022 FY | 6.99 Billion EUR | 22.31% |
| 2022 Q2 | 6.24 Billion EUR | 5.34% |
| 2022 Q4 | 6.99 Billion EUR | -1.34% |
| 2021 Q4 | 5.71 Billion EUR | 0.59% |
| 2021 Q2 | 5.21 Billion EUR | 0.0% |
| 2021 FY | 5.71 Billion EUR | 26.78% |
| 2021 Q1 | - EUR | -100.0% |
| 2021 Q3 | 5.68 Billion EUR | 9.06% |
| 2020 Q4 | 4.48 Billion EUR | 7.98% |
| 2020 Q3 | 4.15 Billion EUR | 7.87% |
| 2020 FY | 4.51 Billion EUR | 56.11% |
| 2020 Q1 | 2.93 Billion EUR | 2.48% |
| 2020 Q2 | 3.85 Billion EUR | 30.98% |
| 2019 Q3 | 2.82 Billion EUR | 4.02% |
| 2019 FY | 2.88 Billion EUR | 13.58% |
| 2019 Q4 | 2.86 Billion EUR | 1.51% |
| 2019 Q2 | 2.71 Billion EUR | 2.16% |
| 2019 Q1 | 2.65 Billion EUR | 5.23% |
| 2018 Q2 | 2.41 Billion EUR | 2.74% |
| 2018 Q3 | 2.51 Billion EUR | 3.99% |
| 2018 Q1 | 2.35 Billion EUR | 2.45% |
| 2018 FY | 2.54 Billion EUR | 9.75% |
| 2018 Q4 | 2.52 Billion EUR | 0.47% |
| 2017 Q2 | 2.29 Billion EUR | 0.53% |
| 2017 FY | 2.31 Billion EUR | 31.2% |
| 2017 Q4 | 2.29 Billion EUR | -0.36% |
| 2017 Q3 | 2.3 Billion EUR | 0.63% |
| 2017 Q1 | 2.27 Billion EUR | 30.04% |
| 2016 Q1 | 1.49 Billion EUR | 3.73% |
| 2016 Q4 | 1.75 Billion EUR | 1.0% |
| 2016 Q3 | 1.73 Billion EUR | 3.69% |
| 2016 Q2 | 1.67 Billion EUR | 12.27% |
| 2016 FY | 1.76 Billion EUR | 22.94% |
| 2015 Q1 | 1.3 Billion EUR | 2.86% |
| 2015 FY | 1.43 Billion EUR | 12.9% |
| 2015 Q4 | 1.43 Billion EUR | 3.2% |
| 2015 Q3 | 1.39 Billion EUR | 4.37% |
| 2015 Q2 | 1.33 Billion EUR | 1.91% |
| 2014 Q2 | 1.2 Billion EUR | 2.71% |
| 2014 Q1 | 1.17 Billion EUR | -0.48% |
| 2014 FY | 1.27 Billion EUR | 7.76% |
| 2014 Q4 | 1.27 Billion EUR | 2.59% |
| 2014 Q3 | 1.24 Billion EUR | 2.77% |
| 2013 Q1 | 1.09 Billion EUR | 2.2% |
| 2013 Q3 | 1.1 Billion EUR | 0.92% |
| 2013 Q4 | 1.18 Billion EUR | 6.73% |
| 2013 Q2 | 1.09 Billion EUR | 0.2% |
| 2013 FY | 1.18 Billion EUR | 10.31% |
| 2012 Q4 | 1.07 Billion EUR | 0.0% |
| 2012 FY | 1.07 Billion EUR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Cegedim SA | 924.06 Million EUR | -955.691% |
| Guerbet SA | 1.02 Billion EUR | -851.512% |
| Nexus AG | 411.71 Million EUR | -2269.425% |
| Bastide Le Confort Médical SA | 647.06 Million EUR | -1407.618% |
| Revenio Group Oyj | 137.4 Million EUR | -6999.927% |
| Drägerwerk AG & Co. KGaA | 3.25 Billion EUR | -199.577% |
| LNA Santé SA | 1.5 Billion EUR | -547.274% |
| Siemens Healthineers AG | 46.68 Billion EUR | 79.104% |
| Medios AG | 594.75 Million EUR | -1540.227% |
| Equasens Société anonyme | 394.04 Million EUR | -2375.682% |
| Stratec SE | 479.53 Million EUR | -1934.342% |